PRIMITIVE NEUROECTODERMAL TUMOR
Clinical trials for PRIMITIVE NEUROECTODERMAL TUMOR explained in plain language.
Never miss a new study
Get alerted when new PRIMITIVE NEUROECTODERMAL TUMOR trials appear
Sign up with your email to follow new studies for PRIMITIVE NEUROECTODERMAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: testing a safer, Half-Matched transplant
Disease control Recruiting nowThis study is testing the safety of a new type of stem cell transplant for children whose cancers have come back or are very hard to treat. Doctors use a half-matched family donor and a special process to remove certain immune cells from the transplant, aiming to reduce complicat…
Matched conditions: PRIMITIVE NEUROECTODERMAL TUMOR
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Doctors test Direct-to-Brain cell therapy for Kids' devastating tumors
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for children and young adults with aggressive or returning brain tumors. Doctors collect a patient's own immune cells, engineer them in a lab to target a protein (B7H3) found on tumor cells, and then deliver these 'CAR T cells'…
Matched conditions: PRIMITIVE NEUROECTODERMAL TUMOR
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC